Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Janssen Inc.
Participants will be selected for this registry using a non-probability sampling method.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Participant is starting infliximab, golimumab, golimumab Intravenous (I.V) or ustekinumab at the time of enrollment and is biologic naive or has been treated with only one prior biologic (including infliximab, golimumab, golimumab I.V or ustekinumab) prior to enrollment
Participant has signed the approved informed consent form
Participant is diagnosed with RA, AxSpA or PsA and is eligible for treatment with infliximab, golimumab, golimumab I.V or ustekinumab in accordance with routine clinical care and the Canadian Product Monograph.
You may not be if
\- Participant was treated with two or more biologics, for any period of time before enrollment
Clareo Health | Biologic Treatment Registry Across Canada
